The early NNMT-inhibitor paper contains several stages of compound characterization. Passing one kind of assay does not establish all the properties needed for a useful human treatment. Primary paper
Research components
The investigators examined membrane permeability, selectivity against selected enzymes, and cellular metabolic responses across a series of small-molecule NNMT inhibitors. The 5-amino-1MQ mouse experiment lasted 11 days, with nine mice per group reported in the figure legend. The paper reported reductions in body weight and white-adipose measures in diet-induced obese mice. This was preclinical work, not a human efficacy trial. Primary record
Our appraisal: an evidence ladder with separate steps
Permeability asks whether and how a compound crosses a specified test barrier. Enzyme selectivity asks how activity differs across the tested panel. A cellular metabolite assay asks another question, and an animal body-composition experiment another again. Each should keep its own system and uncertainty.
For a hypothetical example, a compound could cross a model membrane readily but be rapidly transformed in a living organism. Conversely, a compound could inhibit an isolated target without reaching that target in sufficient form in a different experiment. These possibilities explain why one favorable assay cannot substitute for the remaining work.
Selective against what?
The early study tested DNMT1, PRMT3, COMT, NAMPT and SIRT1 under specified assay conditions. Its results support a limited comparison with those tested proteins. The NAMPT experiment also encountered readout interference above its usable concentration range. An assay ceiling is a limit on the available result, not evidence about activity at every untested exposure. Early study, section 3.6 and Table 3
In the 2024 paper, screening at 10 micromolar produced 67.4% inhibition of human monoamine oxidase A, or MAO-A. The authors discussed this finding as a possible contributor to the glucose-tolerance observations and identified off-target optimization as future work. This is a laboratory screening result, not a measured human interaction rate or proof that MAO-A explains the mouse response. Metabolic study, off-target results and Discussion
The later result does not erase the earlier NNMT data. It does make broad claims such as “no off-target effects” untenable. Different panels asked different questions, and the expanded panel found an additional interaction.
The mouse findings likewise need duration and denominators. We would inspect randomization, masking, body-composition methods, food-intake measurements, and complete adverse observations. A short observation without detected harm does not establish long-term human safety.
Cell viability is conditional evidence
The early research examined 5-amino-1MQ alongside related inhibitors in mouse pre-adipocytes. It reported concentration-dependent cytotoxic findings at higher experimental exposures, while lower tested conditions had less effect on viability. The prose and figure legend do not describe every boundary identically, which is an additional reason to avoid declaring a precise universal “safe concentration” from this article. Early study, section 3.2 and Figure 1
A cell viability result concerns that cell system, its exposure duration and its measurement method. It does not assess every organ, reproductive outcome, immune effect or delayed consequence. Conversely, cytotoxicity at a laboratory concentration does not by itself identify a clinically attainable harmful exposure.
Frequently asked questions
Is 5-amino-1MQ a peptide?
No. The study concerns small-molecule NNMT inhibitors.
Was every assay performed in mice?
No. The paper includes separate laboratory and animal components.
Does membrane permeability prove oral clinical effectiveness?
No. Several additional exposure and outcome questions remain.
Does enzyme selectivity mean no possible off-target effects?
No. The tested panel and conditions limit that inference.
Is this the later 28-day metabolic study?
No. This is the earlier report indexed as PMID 29155147.
Can mouse exposure be converted into self-use instructions?
This record does not provide or validate such a conversion.
What was inspected?
The primary indexed abstract, permeability descriptions, and mouse figure legend. A complete methods and publication-history appraisal remains pending.